Mable was founded by Roman Rothaermel, Inna Thalmann, Chris Eijsbouts, Kumeren Govnder in 2019.

Who are Mable's investors?

Mable's investors include Initialized Capital, Underscore VC, Venrock, Y Combinator, Arkitekt Ventures, First In Ventures, G20 Ventures, Harvard Management Company.

Where is Mable headquartered?

Mable is headquartered in London, GB.

Mable

AcquiredYC S21

London, GB · Founded 2019 · 7 employees · 9 known investors

Find your way into Mable

Paths you didn't know you had: your email and LinkedIn already hold routes to the Mable team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.

Also known as Neurolytic Healthcare, Inc. · DiveHealth · Neurolytic Healthcare · Neurolytic Healthcare Ltd. · Neurolytic Healthcare Ltd., Neurolytic Healthcare, DiveHealth, mable

AI & Machine Learning Biotech Digital Health Healthtech Medical Devices Health Tech Telehealth GenomicsUnited KingdomUnited States of AmericaEuropeAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (S21)

Mable was founded in 2019 by Roman Rothaermel, Inna Thalmann, Chris Eijsbouts, and Kumeren Govnder.

Roman Rothaermel FounderRoman Rothaermel holds an MSc in Biology from Tübingen University and an MSc in Neuroscience from Oxford University, where he also completed his PhD studying memory encoding and brain synchronization mechanisms. He has conducted research in neuropharmacology and drug target characterization.

Inna Thalmann FounderInna Thalmann is co-founder and chief operating officer of Mable, a precision medicine company applying genomic sequencing to clinical decision-making. She holds a PhD in Econometrics with a health economics focus from the University of Oxford and completed postdoctoral research on phenotype algorithms for clinical trial design.

Chris EijsboutsFounder

Kumeren Govnder

Arik KellerFounder

Eric CarlstromFounder

Investors · 9

Initialized Capital✓ confirmed by MableSan Francisco · $1M – $5M

How we know: the company's own site · Y Combinator's founder network · Not right? Tell us

Underscore VClisted by Underscore VCBoston

How we know: Underscore VC's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Venrocklisted by VenrockPalo Alto · $500K – $10M

How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · healthcareservicesinvestmentnews.com · open dataset · 5k.vc investor directory · Not right? Tell us

Arkitekt VenturesreportedNew York · $100K – $10M

How we know: healthcareservicesinvestmentnews.com · Y Combinator's founder network · Not right? Tell us

First In VenturesreportedMiddletown · $50K – $200K

How we know: healthcareservicesinvestmentnews.com · Y Combinator's founder network · Not right? Tell us

G20 VenturesreportedCambridge · $2M – $5M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Harvard Management CompanyreportedAllston

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 1

Illuminalead

Funding

SEC filings, press & company announcements

Undisclosed amountseedJul 2022
Illumina (lead), Y Combinator (lead), Arkitekt Ventures, First In Ventures
Source ↗
Undisclosed amountSeedOct 2019
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Probably GeneticProbably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers. The company works with patient advocacy groups to connect patients with genetic conditions to diagnostic services and community support.

Nest GenomicsNest Genomics develops genomics solutions to integrate genetic testing into routine patient care. The company is led by former Clear Genetics founders and employs genetic counselors and engineers.

RonanRx Inc.RonanRx offers personalized GLP-1 weight-management care delivered via text, where a licensed physician reviews a patient's history to set an individualized dose, titration schedule, and patient-specific adjunct, and a licensed pharmacist at the patient's selected pharmacy verifies and releases compounded, patient-specific prescriptions. It serves individual patients in the US (availability varies by state) and plans to add hormone therapy (HRT).

Blueberry PediatricsBlueberry Pediatrics provides 24/7 telemedicine consultations with board-certified pediatricians for families, supplemented by an at-home diagnostic kit to expand diagnosis capabilities and reduce urgent care visits.

Standard MedicalStandard Medical is a primary care clinic that uses AI under physician supervision, with a licensed physician making every clinical decision while AI gradually takes on clinical tasks. It aims to lower costs and expand access to care, and plans to see its first patients in Utah in 2026.

Companies working in the same space as Mable.

Legal entities · 1

corporate structure

Neurolytic Healthcare, Inc.

In the news

Introducing Mable. Revolutionizing Migraine Care, through the Power of DNA.trymable.com · Jul 2022

Frequently asked questions

What does Mable do?: Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.
Who founded Mable?: Mable was founded by Roman Rothaermel, Inna Thalmann, Chris Eijsbouts, Kumeren Govnder in 2019.
Who are Mable's investors?: Mable's investors include Initialized Capital, Underscore VC, Venrock, Y Combinator, Arkitekt Ventures, First In Ventures, G20 Ventures, Harvard Management Company.
Where is Mable headquartered?: Mable is headquartered in London, GB.